Results

Total Results: 398 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

181. Evidence Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
     January 19, 2021 - Data on the effectiveness and safety of electronic cigarettes for smoking cessation among adults are … only slightly fewer women with preterm birth in the NRT group, 99 , 109 and the study with the fewest patients … pharmacotherapy plus behavioral support—all interventions that may be readily available to primary care patients … Patient Prefer Adherence . 2018;12:2065-2084. doi:10.2147/ PPA.S169397 40. … Efficacy and safety of varenicline for smoking cessation in schizophrenia: a meta-analysis.

182. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
     March 01, 2004 - Little is known about patient preferences for screening. … Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. … the low prevalence of anti-HCV antibodies (0.2% to 0.4% in those 6 to 19 years old)3 and the unclear safety … and efficacy of treatment in this population.172 We also excluded pregnant women because of unclear safety … For treatment of chronic HCV infection, we focused on evidence regarding efficacy and safety 33 Screening

183. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - Little is known about patient preferences for screening. … Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. … low prevalence of anti-HCV antibodies (0.2% to 0.4% in those 6 to 19 years old) 3 and the unclear safety … and efficacy of treatment in this population. 172 We also excluded pregnant women because of unclear safety … For treatment of chronic HCV infection, we focused on evidence regarding efficacy and safety of pegylated

184. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/WN7F3WW6RQFDkHay87a3Dx
     November 18, 2020 - Clinicians should understand the evidence but individualize decision-making to the specific patient or … (PDQ)–Patient Version (https://www.cancer. … gov/types/lung/patient/lung-screening-pdq) • Lung Cancer Screening (PDQ)–Health Professional Version … Only 17% of patients present with localized disease. … Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of

185. Archived: Final Evidence Summary: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     October 15, 2009 - more risk factors provide similar prognostic information, then convenience, availability, cost, and safety … For some of these criteria (such as test reliability, convenience, cost, or safety), we used information … Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention … Oral health indicators poorly predict coronary heart disease deaths. J Dent Res . 2003;82:713-8. … Mortality over a period of 10 years in patients with peripheral arterial disease.

186. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review fo the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k_QR3hvh2jVSPPLu6Q6m6r
     November 13, 2022 - 771. doi:10.1001/jama.2022.12138 Editorial page 716 Multimedia Related article page 746 and JAMA Patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … systematic review of randomized placebo-controlled trials to aid individual patient choice. … Statin safety and associated adverse events: a scientific statement from the American Heart Association

187. Evidence Summary: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
     December 10, 2019 - of the rescreening studies included in KQ2 were not conducted because of substantial differences in patient … 70 The 2 oldest registries reported slightly higher mortality rates from EVAR (1.1% in Australian Safety … https://vascular.org/patient-resources/vascular-conditions/abdominalaortic-aneurysm . … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … , American College of Surgeons National Surgical Quality Improvement Program; ASERNIP-S, Australian Safety

188. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
     June 20, 2017 - and Drug Administration reviews for generics are focused on bioequivalence rather than efficacy and safety … Efficacy of Interventions by Patient Subgroups Key Question 4c. … Orlistat Gastrointestinal adverse effects were very common among patients taking orlistat. … Safety and efficacy of Xenical in children and adolescents with obesity-related diseases [NCT00001723 … Orlistat 3 (RCTs) n = 779 Gastrointestinal adverse effects were very common among patients

189. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/5W2k4HLBPLPgHov6sSvuMH
     July 24, 2018 - key questions that the reviewwill address to allow the USPSTF to evaluate the effectiveness and safety … Related article page 394 and JAMA Patient Page page 414 404 JAMA January 29, 2019 Volume 321, Number

190. Preeclampsia Screening Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
     April 25, 2017 - 16):1668-1683. doi:10.1001/jama.2016.18315 Editorial page 1629 Related article page 1661 and JAMA Patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … h A test performance statistic used to measure what proportion of patients who test positive have the … i A test performance statistic used to measure what proportion of patients who test negative do not have … Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

191. Screening for Suicide Risk in Adults: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cJSpoZqW2M7czx_-GeTdtE
     May 01, 2004 - Most identified high-risk patients are likely admitted to a psychiatric unit for safety, which may or … Evaluation of out-patient counselling compared with general practitioner care following overdoses. … Domiciliary and out-patient treatment of self-poisoning patients by medical and non-medical staff. … The management of non-compliance with referral to out-patient after-care among attempted suicide patients … Intensive in-patient and community intervention versus routine care after attempted suicide.

192. Archived: Final Evidence Summary: Suicide Risk: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary48/suicide-risk-screening-2004
     May 15, 2004 - A letter the physicians could forward to the patient inviting him or her to make an appointment. … Most identified high-risk patients are likely admitted to a psychiatric unit for safety, which may or … Domiciliary and out-patient treatment of self-poisoning patients by medical and non-medical staff. … The management of non-compliance with referral to out-patient after-care among attempted suicide patients … Intensive in-patient and community intervention versus routine care after attempted suicide.

193. Recommendation: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-in-adults-screening
     September 24, 2019 - Clinicians should understand the evidence but individualize decision making to the specific patient or … choice of antibacterial regimen for treatment of asymptomatic bacteriuria during pregnancy is based on safety … Both studies included patients screened at the first prenatal visit with urine culture and treated on … Patients in the control groups had higher rates of pyelonephritis than those in the treatment groups … Clinicians should understand the evidence but individualize decision making to the specific patient or

194. Archived: Final Recommendation Statement: Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/depression-in-adults-screening
     January 26, 2016 - Clinicians should understand the evidence but individualize decisionmaking to the specific patient or … Depression has a major effect on quality of life for the patient and affects family members, especially … There was also insufficient evidence to assess differences in effectiveness for patient subgroups. … was drawn from a good-quality comprehensive systematic review on the comparative effectiveness and safety … https://www.aafp.org/patient-care/clinical-recommendations/all/depression.html .

195. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
     June 20, 2019 - in clinical outcomes compared to delayed treatment until the patient is symptomatic? … Routine voluntary HIV screening in STD clinic clients: characterization of infected clients. … AIDS Patient Care STDS. 1999; 13:473-9. [PMID: 10800526] 39. … Anonymous HIV test- ing: does it attract clients who would not seek confidential testing? … A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclo- vir for prophylaxis

196. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
     February 01, 2023 - Education as Topic"[Mesh] OR "Patient Education Handout" [Publication Type] OR "patient education"[ … Education as Topic"] OR [mh "Patient Education Handout"] OR "patient education" OR [mh Counseling] … • Spectrum of patients included in study. … The VIBLOK SAfety and perFormancE Trial. 2017. Exclusion Code: X4. 50. NCT04294030. … menopausal for ≥12 months) 2-arm RCT comparing 1) valacyclovir and 2) placebo Adverse events and safety

197. Shared Decision-Making About Screening and Chemoprevention: A Suggested Approach (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/sharedba.pdf
     January 01, 2004 - style of patient interaction, but does have suggestions for clinicians on how to interact with patients … to patients. … Physicians and patients: a history of silence. The silent world of doctor and patient. … Impact of patient activation intervention in diabetic patients. … Using statistical risk information to assess oral contraceptive safety.

198. Recommendation: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
     April 28, 2020 - The USPSTF makes recommendations about the effectiveness of specific preventive care services for patients … rigorous review of existing peer-reviewed evidence and are intended to help primary care clinicians and patients … Key Substance Use and Mental Health Indicators in the United States. … Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial. … https://www.aafp.org/patient-care/clinical-recommendations/all/tobacco-use-children.html .

199. Archived: Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
     October 23, 2018 - JAMA Patient … Clinicians should understand the evidence but individualize decision making to the specific patient or … Clinical Considerations Patient … PVS includes 3 items that assess physical abuse and safety. … Some comments asked for clarification about the patient population, including whether men and older women

200. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - assessing the risk for preeclampsia and discuss the benefits and harms of low-dose aspirin use with their patients … Implementation Risk factors, based on medical history, may help guide clinicians and their patients … In October 2020, the US Food and Drug Administration released a safety drug communication warning that … Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later